Ignite Creation Date:
2024-05-06 @ 12:45 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03837184
Status:
COMPLETED
Last Update Posted:
2022-11-22
First Post:
2019-02-08
Brief Title:
Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies
Sponsor:
Novartis Gene Therapies
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-08
First Submit QC Date:
February 8 2019
Study First Post Date:
2019-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-01-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-18
Last Update Post Date:
2022-11-22
Last Update Post Date Type:
ACTUAL